# Interactive Strength, Inc.: overview TRNR · Nasdaq · CIK 1785056 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/trnr.md) · [Financials](/companies/trnr/financials.md) · [Filings](/companies/trnr/filings.md) · [Insiders](/companies/trnr/insiders.md) Latest reported revenue: [$6.6m](/filings/0001193125-26-352477.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-352477). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [2,014](/filings/0001193125-25-283081.md) | [2,383 d](/filings/0001193125-26-134836.md) | [1,356](/filings/0001193125-26-232775.md) | [1,219](/filings/0001193125-26-352477.md) | [4,815](/filings/0001193125-25-283081.md) | [4,139 d](/filings/0001193125-26-134836.md) | [5,141](/filings/0001193125-26-232775.md) | [6,647](/filings/0001193125-26-352477.md) | | Gross margin | % | [(14.3%)](/filings/0001193125-25-283081.md) | [(17.2%) d](/filings/0001193125-26-134836.md) | [(22.4%)](/filings/0001193125-26-232775.md) | [(15.9%)](/filings/0001193125-26-352477.md) | [17.1%](/filings/0001193125-25-283081.md) | [14.1% d](/filings/0001193125-26-134836.md) | [31.3%](/filings/0001193125-26-232775.md) | [48.4%](/filings/0001193125-26-352477.md) | | Operating margin | % | [(385.0%)](/filings/0001193125-25-283081.md) | [(172.4%) d](/filings/0001193125-26-134836.md) | [(465.5%)](/filings/0001193125-26-232775.md) | [(477.8%)](/filings/0001193125-26-352477.md) | [(125.3%)](/filings/0001193125-25-283081.md) | [(40.9%) d](/filings/0001193125-26-134836.md) | [(77.6%)](/filings/0001193125-26-232775.md) | [(50.7%)](/filings/0001193125-26-352477.md) | | Net margin | % | [(354.6%)](/filings/0001193125-25-283081.md) | [(241.8%) d](/filings/0001193125-26-134836.md) | [(486.9%)](/filings/0001193125-26-352477.md) | [(178.8%)](/filings/0001193125-26-352477.md) | [(108.6%)](/filings/0001193125-25-283081.md) | [(240.5%) d](/filings/0001193125-26-134836.md) | [(209.0%)](/filings/0001193125-26-352477.md) | [(106.9%)](/filings/0001193125-26-352477.md) | | Diluted EPS | $ per share | [(1534.56)](/filings/0001193125-25-283081.md) | not reported | [(173.58)](/filings/0001193125-26-232775.md) | [(149.29)](/filings/0001193125-26-352477.md) | [(3.11)](/filings/0001193125-25-283081.md) | not reported | [(10.24)](/filings/0001193125-26-232775.md) | [(17.37)](/filings/0001193125-26-352477.md) | | Free cash flow | $k | not reported | not reported | [(3,545)](/filings/0001193125-26-232775.md) | [(2,198) d](/filings/0001193125-26-352477.md) | not reported | not reported | [(2,684)](/filings/0001193125-26-232775.md) | [(3,286) d](/filings/0001193125-26-352477.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [0.7](/filings/0000950170-24-039531.md) | [1.0](/filings/0000950170-25-047848.md) | [5.4](/filings/0001193125-26-134836.md) | [11.5](/filings/0001193125-26-134836.md) | | Gross margin | % | [(1302.2%)](/filings/0000950170-24-039531.md) | [(574.6%)](/filings/0000950170-25-047848.md) | [(51.6%)](/filings/0001193125-26-134836.md) | [7.9%](/filings/0001193125-26-134836.md) | | Operating margin | % | [(7980.2%)](/filings/0000950170-24-039531.md) | [(5663.2%)](/filings/0000950170-25-047848.md) | [(542.5%)](/filings/0001193125-26-134836.md) | [(172.2%)](/filings/0001193125-26-134836.md) | | Net margin | % | [(8549.9%)](/filings/0000950170-24-039531.md) | [(5340.2%)](/filings/0000950170-25-047848.md) | [(649.3%)](/filings/0001193125-26-134836.md) | [(207.9%)](/filings/0001193125-26-134836.md) | | Diluted EPS | $ per share | [(119.49)](/filings/0000950170-24-039531.md) | [(16614.85)](/filings/0000950170-25-047848.md) | [(16328.50)](/filings/0001193125-26-134836.md) | [(171.77)](/filings/0001193125-26-134836.md) | | Free cash flow | $m | [(36.1)](/filings/0000950170-24-039531.md) | [(15.4)](/filings/0000950170-25-047848.md) | [(14.8)](/filings/0001193125-26-134836.md) | [(10.5)](/filings/0001193125-26-134836.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/trnr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.5k | 750 | | New +750 | | [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $51 | 10,924 | | New +10,924 | ## Recent filings [All 322 filings](/companies/trnr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 20:15 ET | [8-K](/filings/0001193125-26-420445.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-420445 | | 2026-09-01 | 21:00 ET | [8-K](/filings/0001193125-26-378586.md) | 5.07 Shareholder vote results | 0001193125-26-378586 | | 2026-08-17 | 10:05 ET | [DEF 14A](/filings/0001193125-26-353153.md) | Proxy statement, period 2026-08-14 | 0001193125-26-353153 | | 2026-08-14 | 20:45 ET | [10-Q](/filings/0001193125-26-352477.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352477 | | 2026-08-14 | 20:31 ET | [8-K](/filings/0001193125-26-352422.md) | 3.02 Unregistered sale of equity | 0001193125-26-352422 | | 2026-08-07 | 20:15 ET | [8-K](/filings/0001193125-26-340285.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-340285 | | 2026-07-31 | 20:15 ET | [8-K](/filings/0001193125-26-328605.md) | 3.02 Unregistered sale of equity | 0001193125-26-328605 | | 2026-07-24 | 20:30 ET | [8-K](/filings/0001193125-26-316159.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-26-316159 | | 2026-07-09 | 21:15 ET | [8-K](/filings/0001193125-26-299839.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-299839 | | 2026-07-07 | 20:30 ET | [8-K](/filings/0001193125-26-297535.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-297535 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-134836.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/83a5b450-beaf-4bf5-9222-40b168d8f24b) ## About the filer - CIK: 1785056 - Tickers: TRNR - Exchange: Nasdaq - SIC code: 3600 Electronic & Other Electrical Equipment (No Computer Equip) - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.